Gerardo Guillén

A novel cancer vaccine composed of human-recombinant epidermal growth factor linked to a carrier protein: Report of a pilot clinical trial

Gabriela Gonzalez, Tania Crombet, Mauricio Catalá et al. · Annals of Oncology · 1998 · 154 citations · Full text

Pilot Clinical Trial, Vaccine Development, Carrier Protein +10

Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens

Arístides Aguilar Betancourt, C.A. González Delgado, Zurina Cinza Estévez et al. · International Journal of Infectious Diseases · 2007 · 96 citations · Full text

Treatment of chronic hepatitis B naïve patients with a therapeutic vaccine containing HBs and HBc antigens (a randomized, open and treatment controlled phase III clinical trial)

Mamun Al Mahtab, Sheikh Mohammad Fazle Akbar, Julio Aguilar et al. · PLoS ONE · 2018 · 89 citations · Full text

C-Phycocyanin is neuroprotective against global cerebral ischemia/reperfusion injury in gerbils

Giselle Pentón‐Rol, Javier Marín‐Prida, Gilberto L. Pardo‐Andreu et al. · Brain Research Bulletin · 2011 · 87 citations

Cerebral Vascular Regulation, Neurophysiology, Medicine +13

Development of a nasal vaccine for chronic hepatitis B infection that uses the ability of hepatitis B core antigen to stimulate a strong Th1 response against hepatitis B surface antigen

JC Aguilar, Yadira Lobaina, Verena Muzio et al. · Immunology and Cell Biology · 2004 · 85 citations

Viral Immunity, Immunology, Hepatitis B +16